
1. malar j. 2017 jan 13;16(1):27. doi: 10.1186/s12936-017-1680-8.

rapid decline susceptibility plasmodium falciparum to
dihydroartemisinin-piperaquine south vietnam.

thanh nv(1), thuy-nhien n(2), tuyen nt(1), tong nt(1), nha-ca nt(1), dong lt(3), 
quang hh(4), farrar j(1)(5), thwaites g(1)(5), white nj(5)(6), wolbers m(1)(5),
hien tt(1)(5).

author information: 
(1)oxford university clinical research unit, wellcome trust major overseas
programme, 764 vo van kiet street, ward 1, district 5, ho chi minh city, vietnam.
(2)oxford university clinical research unit, wellcome trust major overseas
programme, 764 vo van kiet street, ward 1, district 5, ho chi minh city, vietnam.
nhienntt@oucru.org.
(3)institute malariology, parasitology, entomology, ho chi minh city,
vietnam.
(4)institute malariology, parasitology, entomology, qui nhon, vietnam.
(5)nuffield department medicine, centre tropical medicine global
health, university oxford, oxford, uk.
(6)mahidol oxford tropical medicine research unit, mahidol university, bangkok,
thailand.

background: artemisinin resistant plasmodium falciparum emerged the
countries greater mekong sub-region posing serious threat global
malaria elimination efforts. relationship artemisinin resistance to
treatment failure unclear.
methods: annual studies conducted three malaria endemic provinces the
south vietnam (binh phuoc, ninh thuan gia lai) 2011 2015, 489 
patients uncomplicated p. falciparum malaria enrolled detailed
clinical, parasitological molecular therapeutic response assessments with
42 days follow up. patients received national recommended first-line
treatment dihydroartemisinin-piperaquine three days.
results: 5 years proportion patients detectable parasitaemia
on day 3 rose steadily 38 57% (p < 0.001). binh phuoc province, the
parasite clearance half-life increased 3.75 h 2011 6.60 h 2015
(p < 0.001), treatment failures rose 0% 2012 2013, 7% in
2014 26% 2015 (p < 0.001). recrudescence associated vitro
evidence artemisinin piperaquine resistance. treatment failures
cases 2015, 14 parasite isolates carried c580y pfkelch 13 gene, marker
of artemisinin resistance 93% (13/14) carried exoe415g mutations,
markers piperaquine resistance.
conclusions: south vietnam recent emergence piperaquine resistant p.
falciparum strains accelerated reduced response artemisinin has
led treatment failure rates 26% dihydroartemisinin-piperaquine,
vietnam's current first-line act. alternative treatments urgently needed.

doi: 10.1186/s12936-017-1680-8 
pmcid: pmc5237149
pmid: 28086775  [indexed medline]

